Navigation Links
Quantros Director of Patient Safety and Risk Management is Elected Co-Chair of Patient Safety Special Interest Group (PSSIG) at HL7
Date:1/22/2009

Dr. Ali Rashidee Will Serve as Co-Chair for the PSSIG for a Three-Year Term

SAN FRANCISCO, Jan. 22 /PRNewswire/ -- Dr. Ali Rashidee, Quantros Director for Safety and Risk Management, has been elected Co-Chair for the HL7 Patient Safety Special Interest Group (PSSIG). This international organization's ongoing mission is to simplify the implementation of interfaces between health care applications for the exchange of key sets of clinical data minimizing the need for custom interface programming and program maintenance. The HL7 PSSIG is the body tasked with defining the standardized language and associated taxonomy and classification schema as it relates to patient safety.

Dr. Rashidee is currently the Director of Product Management for Safety and Risk Solutions at Quantros. He has spent a large part of his career enhancing healthcare informatics for the betterment of healthcare safety and quality. In his current role at Quantros, Dr. Rashidee is responsible for ensuring Quantros Safety and Risk Management (SRM) solutions contain an extensive taxonomy and classification schema in alignment with national and international standards. SRM applications are used by more than 900 healthcare facilities throughout the United States. As a Co-Chair of the HL7 PSSIG, Dr. Rashidee's knowledge and experience with data nomenclature and standardization will help further the group's data interoperability endeavors.

"One of the key factors to improving patient safety is the ability for healthcare leadership to have right data presented across the systems to make fiscally sound decisions about environment of care and process improvement," according to Dr. Rashidee. "The HL7 PSSIG is focused on defining a standardized, common nomenclature for patient safety that breaks down data silos, facilitates interoperability and enables systems to provide a common language across healthcare technology solutions. I am honored to have been selected as a Co-Chair to help lead this very important endeavor."

"The work of the HL7 PSSIG is a vital component for creating system interoperability in the area of patient safety," states Sanjaya Kumar, MD, President and CEO for Quantros. "Dr. Rashidee's experience in clinical informatics and patient safety taxonomy development and management with organizations such as AHRQ, PSO-PPC, NHSN and FDA are a perfect complement to this team and its goals."

About Quantros

Quantros provides real-time solutions for safety and risk management, outcomes and performance monitoring, accreditation and compliance and surveillance and decision support for leading healthcare providers throughout the nation. Quantros' web-delivered applications provide a standard platform that creates actionable knowledge to help clients save lives, improve quality and conserve assets. Through a variety of direct sales and vendor partners, more than 2,000 healthcare facilities use Quantros web-based technology solutions every day.

Quantros team members include physicians, nurses and healthcare professionals as well as an experienced team of information technology specialists.

Quantros website: www.quantros.com

About HL7

Founded in 1987, Health Level Seven, Inc. (www.HL7.org) is a not-for-profit, ANSI accredited standards development organization dedicated to providing a comprehensive framework and related standards for the exchange, integration, sharing and retrieval of electronic health information that supports clinical practice and the management, delivery and evaluation of health services. HL7's more than 2,300 members represent approximately 500 corporate members, which include more than 90 percent of the information systems vendors serving healthcare.

HL7's endeavors are sponsored, in part, by the support of its benefactors: Accenture; Booz Allen Hamilton; Centers for Disease Control and Prevention; Duke Translational Medicine Institute (DTMI); Eclipsys Corporation; Eli Lilly & Company; Epic Systems Corporation; the Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; IBM; Intel Corporation; InterSystems Corporation; Kaiser Permanente; Lockheed Martin; McKesson Provider Technologies; Microsoft Corporation; NHS Connecting for Health; NICTIZ National Healthcare; Novartis; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Healthcare; QuadraMed Corporation; Quest Diagnostics Inc.; Sanofi-aventis R&D; Siemens Healthcare; St. Jude Medical; Sunquest Information Systems; Thomson Reuters; the U.S. Department of Defense, Military Health System; and the U.S. Department of Veterans Affairs.

Numerous HL7 Affiliates have been established around the globe including Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, India, Ireland, Italy, Japan, Korea, Mexico, The Netherlands, New Zealand, Singapore, Spain, Sweden, Switzerland, Taiwan, Turkey, United Kingdom and Uruguay.

HL7 Website: www.hl7.org


'/>"/>
SOURCE Quantros
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Quantros and ISMP to Partner on PSO Initiatives
2. Quantros and ISMP Announce Collaboration Agreement to Further Medication Safety
3. Quantros Patient Safety Center Receives Certification as a Patient Safety Organization (PSO)
4. Quantros Launches Patient Safety Organization Manager to Streamline PSO Data Management and Submission to the Network of Patient Safety Databases
5. Quantros Expanding Support for Alternative Web Browsers
6. US Pharmacopeia partners with Quantros to enhance the MEDMARX patient safety reporting program
7. PPGI Appoints Rick Strandlund to the Board of Directors
8. Hard To Treat Diseases (HTDS) To Name New CEO and Directors
9. Xmark Sends Letters to Icagens Board of Directors: Questions Companys Leadership as Well as Motives Behind Adoption of Poison Pill
10. The LCA-Vision Full Value Committee Files Preliminary Consent Solicitation Statement to Reconstitute the Board of Directors of LCA-Vision Inc.
11. NUCRYST Pharmaceuticals appoints a new director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. Inc ... honored with a 2016 When Work Works Award for its use of effective workplace ... national When Work Works project administered by the Families and Work Institute (FWI) and ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... ... ... Connor Sports, through its Connor Cares initiative, will continue to ... Legacy Tour that will commemorate the Indiana Fever legend’s hall-of-fame career and final ... and levels of the game, Connor Sports has committed to a significantly increased focus ...
(Date:5/26/2016)... ... 26, 2016 , ... The Woodlands at John Knox Village , Florida’s ... care for living and healing, celebrated its grand opening, today. The Woodlands at John ... provided by Empowered Staff. , “This is an incredibly fulfilling time for John Knox ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... There are ... more than 32 million cancer survivors worldwide. On Sunday, June 5, 2016, communities around ... annual National Cancer Survivors Day®. , National Cancer Survivors Day® is an annual ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... According to a new market ... 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application ... Manufacturers, Hospitals/ Clinics) - Forecast to 2021", published by ... for the forecast period of 2016 to 2021. This ... 2021 from USD 117.3 Million in 2016, at a ...
(Date:5/25/2016)... , May 25, 2016 ... Size, Share, Development, Growth and Demand Forecast to 2022 ... Insulin Pump and Others)" published by P&S Market Research, ... $9,998.3 million in 2015, and it is expected to ... on type, the insulin pump segment is expected to ...
(Date:5/25/2016)... , May 25, 2016 ... employing the precision of circulating tumour DNA (ctDNA) ... announces the appointment of Professor Clive Morris ... medical leadership across the clinical development programme, scientific ... products help deliver significant improvements in clinical outcomes ...
Breaking Medicine Technology: